Results 91 to 100 of about 16,590 (223)
Background: Endothelial dysfunction, hypercoagulability, hemolysis, and vasculopathy are involved in the pathogenesis of sickle cell leg ulcers (SCLUs).
Helen C. Okoye +8 more
doaj +1 more source
Mutations in the thrombomodulin gene are rare in patients with severe thrombophilia
Because thrombomodulin plays a key role in the protein C pathway, we evaluated the contribution of thrombomodulin gene mutations to venous thrombosis.
F. Rodeghiero +4 more
core +1 more source
Our laboratory’s previous microarray analysis of subjects with Plasmodium falciparum revealed up-regulation of Toll-like receptor, NF-kB, TNF-α, IFN-γ, IL-1β, p38 MAPK, and MHC molecules.
Wan-Chung(Wan-Jiung) Hu +5 more
core
Surface Re-engineering of Pancreatic Islets with Recombinant azido-Thrombomodulin
Chemoselective conjugation of an azido-functionalized thrombomodulin to pancreatic islets was achieved by Staudinger ligation to a surface-bound bifunctional poly(ethylene glycol) linker.
Wanxing Cui (323677) +5 more
core +1 more source
Background Vascular endothelial damage is involved in the development and exacerbation of ventilator-induced lung injury (VILI). Pulmonary endothelial glycocalyx and neutrophil extracellular traps (NETs) are endothelial protective and damaging factors ...
Kenichiro Kikuchi +2 more
doaj +1 more source
BackgroundThe mechanism by which combined oral contraceptives (COCs) lead to hypercoagulation is not fully understood, although activated protein C (APC) pathway resistance has been implicated.
Marisa Ninivaggi +6 more
doaj +1 more source
Paclitaxel Induces Thrombomodulin Downregulation in Human Aortic Endothelial Cells
Patients with paclitaxel-eluting stents are at risk of developing stent thrombosis upon premature discontinuation of dual antiplatelet therapy. In this study, we set out to clarify whether paclitaxel can modulate thrombomodulin expression in human aortic
Wang, Huang-Joe +3 more
core
Background Venous thromboembolic events (VTEs) are the second‐leading cause of death in cancer patients, with an incidence of 5%–17% in lymphoma patients, particularly higher in those with non‐Hodgkin lymphoma (NHL). Existing risk assessment models (RAMs)
Wen Li +11 more
doaj +1 more source
Plasma thrombomodulin levels in patients with Behcet's disease
The plasma levels of thrombomodulin in 54 patients with Behcet's disease (BD) and 20 healthy control subjects were studied. The mean thrombomodulin (TM) level was significantly higher in active BD patients than in inactive patients and healthy controls ...
Ayaslioglu, E +5 more
core +1 more source

